Terumo Corp
TSE:4543

Watchlist Manager
Terumo Corp Logo
Terumo Corp
TSE:4543
Watchlist
Price: 2 298 JPY -1.65% Market Closed
Market Cap: 3.4T JPY

Terumo Corp
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Terumo Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Terumo Corp
TSE:4543
Revenue
ÂĄ1.1T
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
8%
Paramount Bed Holdings Co Ltd
TSE:7817
Revenue
ÂĄ107B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
4%
Olympus Corp
TSE:7733
Revenue
ÂĄ969B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
2%
Sysmex Corp
TSE:6869
Revenue
ÂĄ498.7B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Nihon Kohden Corp
TSE:6849
Revenue
ÂĄ229.2B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
3%
JEOL Ltd
TSE:6951
Revenue
ÂĄ200.5B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
7%
No Stocks Found

Terumo Corp
Glance View

Market Cap
3.4T JPY
Industry
Health Care

In the bustling corridors of Tokyo, Terumo Corporation stands as a testament to Japan's prowess in medical innovation, deeply rooted in a legacy that began over 90 years ago. Born from the vision of a group of scientists aiming to improve Japan’s healthcare system, Terumo embarked on its journey by developing high-quality thermometers. This modest start set the stage for what would become a global leader in medical technology. Anchored by its commitment to enhancing patient care and healthcare practices, Terumo carved out a significant niche by focusing on cardiovascular systems, blood transfusion, and cell therapy technologies. As the company grew, it systematically increased its range, moving into areas such as vascular intervention and diabetes care, aligning with evolving medical needs around the globe. Today, Terumo generates its revenue through a multi-faceted business model that thrives on innovation and globalization. It operates through several segments: Cardiovascular, General Hospital, and Blood Management. The Cardiovascular division, a major revenue driver, offers products ranging from stents to heart-lung machines used in cardiac surgeries. Meanwhile, the General Hospital unit provides hospital equipment like infusion pumps and syringe systems, while the Blood Management segment is renowned for its blood and cell processing systems. Terumo’s ability to innovate within these domains enhances its competitive edge by delivering cutting-edge medical solutions. By balancing its expansive product portfolio with a strong focus on research and development, the company not only sustains but frequently advances the standards of modern healthcare, ensuring its continued success in diverse international markets.

Intrinsic Value
2 622.01 JPY
Undervaluation 12%
Intrinsic Value
Price

See Also

What is Terumo Corp's Revenue?
Revenue
1.1T JPY

Based on the financial report for Sep 30, 2025, Terumo Corp's Revenue amounts to 1.1T JPY.

What is Terumo Corp's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Terumo Corp have been 12% over the past three years , 12% over the past five years , and 8% over the past ten years .

Back to Top